GGrantIndex
Sort

15,440 grants matching organoids

Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens

$546,688
Rosalie C Sears · Oregon Health & Science University · U01 · FY2023 · CA

Identification and characterization of cellular factors involved in HCV entry

$546,673
Charles M. Rice · Rockefeller University · R01 · FY2014 · AI

Identification and characterization of cellular factors involved in HCV entry

$546,673
Charles M. Rice · Rockefeller University · R01 · FY2015 · AI

Identification and characterization of cellular factors involved in HCV entry

$546,673
Charles M. Rice · Rockefeller University · R01 · FY2016 · AI

Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology

$546,612
Nikhil Joshi · Yale University · R01 · FY2023 · CA

Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention

$546,464
Ji-Yong Julie Kim · Northwestern University At Chicago · R01 · FY2019 · CA

Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments

$546,433
Josephine A Taverna · University Of Texas Hlth Science Center · R01 · FY2024 · CA

Understanding genetic architecture and host-microbiome interactions in Inflammatory bowel disease in under-represented minority populations and in patients with unmet medical need.

$546,312
Dermot Patrick McGovern · Cedars-Sinai Medical Center · U01 · FY2024 · DK

Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer

$546,296
Laura Carpin Kennedy · Vanderbilt University Medical Center · R01 · FY2024 · CA

Enterovirus interference with rotavirus vaccine replication and immunity

$546,268
Megan T Baldridge · Washington University · R01 · FY2025 · AI

Maintenance of the alveolar niche in emphysema

$546,222
Tien Peng · University Of California, San Francisco · R01 · FY2021 · HL

Mechanisms regulating cellular crosstalk in extrahepatic bile duct responses to injury

$546,181
Nataliya Razumilava · University Of Michigan At Ann Arbor · R01 · FY2024 · DK

Nuclear and non-nuclear functions of NKX3.1 in suppression of prostate cancer

$546,133
Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2025 · CA

Mechanisms of neutrophil extracellular trap formation and contribution to biliary fibrosis in biliary atresia

$545,972
Cara Lynn Mack · Medical College Of Wisconsin · R01 · FY2024 · DK

Mechanisms of neutrophil extracellular trap formation and contribution to biliary fibrosis in biliary atresia

$545,972
Cara Lynn Mack · Medical College Of Wisconsin · R01 · FY2025 · DK

Deciphering the role of p16INK4A+ fibroblasts in lung fibrosis

$545,713
Tien Peng · University Of California, San Francisco · R01 · FY2024 · HL

Organoid models of KRAS mutant cancer

$545,711
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis

$545,630
Yi Tan · University Of Louisville · R01 · FY2023 · HL

Enhancing cone survival in retinitis pigmentosa through cell-specific therapeutic CRISPR editing of a roxadustat target

$545,461
Stephen H Tsang · Columbia University Health Sciences · R01 · FY2022 · EY

Spatially mapping and modeling tuberculosis granulomas to define the immunological determinants of infection outcome

$545,386
Erin McCaffrey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Genetically engineered human pluripotent stem cells as a platform to define the b

$545,374
Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2015 · MH

Genetically engineered human pluripotent stem cells as a platform to define the b

$545,374
Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2016 · MH

The role of RAMS11 in colorectal cancer progression and treatment resistance

$545,341
Christopher A Maher · Washington University · R01 · FY2024 · CA

Mechanotransduction by Melusin in Cardiac Hypertrophy

$545,104
Nathan John Sniadecki · University Of Washington · R01 · FY2020 · HL

Sirtuins and Cancer

$545,051
Marcia Haigis · Harvard Medical School · R01 · FY2024 · CA